Viewing nowCombinationDonggu Jaltan Jeong 5/100 mg (Amlodipine Besilate, Losartan Potassium)
Amlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.

MFDS item code 201502700 · Approved 2015.04.30
Treatment of essential hypertension and Stage II hypertension
This medication is used in patients with essential hypertension who do not achieve adequate blood pressure control with monotherapy using Amlodipine or Losartan. Moreover, it is used as an initial treatment for stage 2 hypertension patients who require combination therapy to reach the treatment goal blood pressure. That is, it is effective in controlling blood pressure in patients with essential hypertension and moderate hypertension who require combination treatment.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the tablet be taken at the same time each day, if possible (e.g., in the morning). Before treatment with this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or losartan). However, if blood pressure is not controlled with monotherapy using an individual component as follows, switching directly to this medicine may be considered. - 5/50 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 50 mg monotherapy. - 5/100 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or losartan 100 mg monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to administer it should be based on factors such as baseline blood pressure, target blood pressure, and the expected degree of attainment of the treatment goal with the combination product compared with the individual products. Usually, this medicine is administered at 5/50 mg once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50 mg once daily. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min); however, administration of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients undergoing dialysis. ○ Patients with reduced effective intravascular volume: Administration of this medicine is not recommended in a small number of patients with reduced effective intravascular volume (e.g., patients being treated with high doses of diuretics). (See section 1. Warnings under Precautions for Use.) ○ Patients with hepatic impairment: Administration of this medicine is not recommended in patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 mg once daily). ○ Older adults: In older adults aged 75 years or older, an initial dose of losartan of 25 mg once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
○ Pediatric patients: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately upon confirmation of pregnancy. Reduced amniotic fluid due to decreased fetal kidney function can lead to issues such as limb contractions or craniofacial deformities. Taking this medication during the early stages of pregnancy may also pose risks to the fetus; therefore, women of childbearing age should consult a physician before use. Patients with reduced intravascular volume, such as those on diuretics, should ensure normal fluid volume before taking this medication; otherwise, hypotension may occur. This medication should not be used in individuals allergic to active ingredients, pregnant or breastfeeding women, patients with severe liver dysfunction, patients with severe aortic stenosis, and patients in a state of shock. Patients undergoing blood tests or with impaired kidney function, patients on a strict sodium-restricted diet, and those with hyperkalemia should use this medication with caution. Taking this medication can cause symptoms such as dizziness or headaches, so caution is advised when driving or operating hazardous machinery. Patients with impaired liver or kidney function should have regular tests and adjust the dosage according to the doctor’s guidance. This medication may enhance the effect when taken with other antihypertensives, so consultation with a specialist is necessary when combining treatments. Especially, avoiding grapefruit juice is advised as it can excessively increase the medication's effectiveness. Risks to the fetus during pregnancy mean that it should be discussed with a doctor if planning a pregnancy or during pregnancy, and use during breastfeeding should be avoided. Safety in children or adolescents under 18 years of age has not been established, and its use is not recommended. Elderly patients, particularly those over 75 years of age, require proper dosage adjustment for this medication and should be guided by a physician during initial treatment. Overdosage can cause severe hypotension and heart problems, so strict adherence to dosage instructions is necessary, and medical attention should be sought immediately if adverse symptoms occur. This medication should be kept out of reach of children and should not be transferred to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and humidity. It is also important to keep it at room temperature between 1 to 30 degrees Celsius, which will help maintain its efficacy and safety.
Light pink rectangular film-coated tablet
30 tablets per bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Huwons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 13.888mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Huons Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
GL Pharma Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 50mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Losartan Potassium 100mg
Tablet · Prescription medication · Combination
Jinyang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.